[1]
Y. R. Verma, “Study of the therapeutic efficacy and safety of intralesional tranexamic acid (25 mg/ml) for the treatment of melasma in male patients: A single centered ‘before-after’ observational study”, Int J Res Dermatol, vol. 7, no. 6, pp. 827–834, Oct. 2021.